Thomas Steyer’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Thomas Steyer’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-340,000	Closed	-$40M	–	102
2015 Q3	$40M	Sell	340,000 -420,000	-55%	-$54.9M	0.53%	43
2015 Q2	$58.8M	Sell	760,000 -400,000	-34%	-$26.2M	0.79%	36
2015 Q1	$67.1M	Sell	1,160,000 -225,000	-16%	-$9.55M	0.98%	36
2014 Q4	$44.7M	Buy	1,385,000 +450,000	+48%	+$13.5M	0.61%	43
2014 Q3	$22.9M	Buy	935,000 +501,186	+116%	+$10.2M	0.37%	55
2014 Q2	$7.69M	Sell	433,814 -66,186	-13%	-$1.07M	0.11%	73
2014 Q1	$10M	Sell	500,000 -62,352	-11%	-$1.21M	0.2%	62
2013 Q4	$9.44M	Buy	562,352 +112,352	+25%	+$1.55M	0.2%	59
2013 Q3	$4.78M	Sell	450,000 -187,500	-29%	-$1.64M	0.1%	66
2013 Q2	$3.56M	Buy	+637,500	New	+$3.86M	0.07%	70

Other funds holding ANAC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Thomas Steyer's ANAC Position: Q4 2015 in Review

Thomas Steyer sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 340,000 shares — an estimated $40M sold.

Thomas Steyer first reported a position in ANAC in Q2 2013 and held it in 10 quarters. The position peaked at $67.1M in Q1 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

Thomas Steyer reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
Thomas Steyer sold 340,000 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $40M.
Thomas Steyer first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 10 quarters.
Thomas Steyer's ANACOR PHARMACEUTICALS INC COM position peaked at $67.1M in Q1 2015.
214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Farallon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.